seekingalpha.comOCT 51 min read$MCK

McKesson, CD&R in talks for $5B deal for Option Care Health: FT

McKesson and private equity firm Clayton, Dubilier & Rice are in advanced talks to acquire Option Care Health, valuing the company at over $5B, including debt. Option Care Health provides medical infusion services.

Original reporting

seekingalpha.com

Published Oct 5, 2026, 8:40 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Oct 5, 2026, 8:41 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefMergers & acquisitions

Primary signal

$MCK

Bullish

high confidence

Mentioned

$MCK · $OPCH

Relevance

9/10

AlphAI data visualization · based on seekingalpha.com

Decision brief

The 30-second read

$MCKBullishHigh

Why it matters

The transaction values OPCH at >$5 billion, indicating a significant strategic expansion for McKesson.

Market read

First‑report M&A deal over $5 billion, likely to move both stocks and affect the healthcare services sector.

What to watch

Financing structure and integration risks may temper upside.

Relevance 9/10Novelty 9/10Timing: immediate today

Background

McKesson (MCK) and private‑equity firm Clayton, Dubilier & Rice are negotiating a takeover of Option Care Health (OPCH).

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$MCKBullishHigh confidence

Context

McKesson is in advanced talks to acquire Option Care Health in a deal valued over $5 billion.

Expected impact

likely upward pressure as market prices in the acquisition premium

Evidence & confidence

Deal size and strategic fit suggest a material positive catalyst for McKesson.

$OPCHBullishHigh confidence

Context

Option Care Health is the target of a $5 billion acquisition by McKesson.

Expected impact

likely upward pressure as investors price in the buyout premium

Evidence & confidence

Buyout announcements typically cause a sharp rise in target company shares.

Market effects

Sector

Consolidation in the medical infusion services sector could pressure peers.

Regional

U.S. healthcare services market sees increased M&A activity.

Global

Large‑cap M&A adds to overall market momentum.

Counterpoint

What could challenge this read

Deal could face regulatory scrutiny, delaying closure and weighing on MCK.

Key entities

Company
McKesson Corporation
U.S. pharmaceutical distributor and healthcare services provider.
Company
Option Care Health
Medical infusion services provider.
Private Equity
Clayton, Dubilier & Rice
Co‑owner of Option Care Health.

Read at source ← All news

OCT 30

$BTSGHighAI 9/10

BrightSpring Soars 12% on Q3 Beat and Raised 2026 Guidance as Adjusted EBITDA Jumps 42%

BrightSpring Health Services (BTSG) stock rose 12% after Q3 earnings beat estimates, with revenue up 26% to $4.21B and adjusted EBITDA up 42% to $228M. The company raised its 2026 guidance. Gross profit per script increased 27%, and home health census grew 58% due to acquisitions from UnitedHealth's Amedisys and LHC Group. Option Care Health (OPCH) and CVS Health (CVS) report next week, which may indicate if BrightSpring's pricing gains are industry-wide.

finance.yahoo.com6 min

OCT 27

$CAHMed

Cardinal Health, McKesson awarded $2.7B and $741.5M DLA contracts respectively

Cardinal Health (CAH) and McKesson (MCK) won DLA contracts worth $2.7B and $741.5M respectively for medical surgical supplies. The contracts last until 2029 with option periods. Customers include military branches and health agencies. Defense working capital funds from 2027-2030 will finance the contracts.

tipranks.com2 min

OCT 27

$MCKLow

Built and Bred

McKesson (MCK) will invest $179M in a 330,000 sq. ft. regional distribution center in Moore, Oklahoma, creating 200+ jobs. The site's location, readiness, and regional coordination influenced the decision, according to the company.

citylifestyle.com2 min

OCT 10

$OPCHMed

Key deals this week: Option Care Health, PTC, Energy Transfer and more

Service Properties Trust (SSVC) received a $2.0B acquisition offer from TKO LLC. Viatris (VTRS) agreed to buy Pacira BioSciences (PCRX) for $1.65B. Option Care Health (OPCH) surged 34% after a $5.8B acquisition deal with CD&R and McKesson (MCK). Energy Transfer (ET) will acquire Vaquero Midstream for $2.625B. Emera (EMA) and Canadian Utilities (CDUAF) agreed to a $10B merger. Cenovus Energy (CVE) will acquire Athabasca Oil (ATHOF) for ~$5.7B.

tradingview.com1 min

OCT 10

$OPCHHighAI 9/10

Option Care Health Sold for $5.8B in CD&R-McKesson Deal

Option Care Health (OPCH) is being acquired by CD&R and McKesson (MCK) for $5.8B, or $32.05 per share, a 37% premium. The deal, expected to close in 2027, values the company at $5.8B. Option Care Health will operate independently post-acquisition. The company reported $5.6B in 2025 revenue and $207.6M in net income, with modest growth in 2026. The acquisition aligns with McKesson's strategy to expand access to innovative therapies.

hoodline.com2 min

OCT 9

$MCKHighAI 9/10

McKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified?

McKesson (MCK) is acquiring Option Care Health (OPCH) for $5.8B, including debt, at $32.05 per share, a 37% premium. McKesson and private equity firm CD&R will own 49% and 51% respectively. The deal expands McKesson's specialty healthcare services. McKesson's Q1 2027 revenue was $105.4B, beating estimates, with adjusted EPS up 20% YoY to $9.93. The company raised its fiscal 2027 adjusted EPS guidance to $44.20-$45.00.

finance.yahoo.com2 min